Divi’s Laboratories Q4 results: PAT surges 26% YoY, revenue up 12%

May 17, 2025

Divi’s Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company’s board declared a dividend of Rs 30 per share and its Unit III greenfield project has commenced commercial operations.

More To Explore

91% of individual F&O traders lost money in FY25 despite Sebi curbs: Study

Market regulator SEBI analyzed trading activity in the equity derivatives segment. The analysis revealed that most individual traders faced net losses in FY25. Index options

July 7, 2025

Nithin Kamath on why Zerodha has intentionally held back on enabling AI-driven order placement

Zerodha CEO Nithin Kamath revealed the firm has intentionally avoided AI-driven order placement. Instead, it’s focused on backend upgrades to stay relevant in an automated

July 7, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003